Arrowstreet Capital’s NxStage Medical Inc. NXTM Stock Holding History

Arrowstreet Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100,800	Closed	-$2.81M	–	1596
2018 Q3	$2.81M	Buy	100,800 +91,100	+939%	+$2.56M	0.01%	633
2018 Q2	$271K	Buy	+9,700	New	+$260K	﹤0.01%	984
2017 Q2	–	Sell	-541,134	Closed	-$14.5M	–	1440
2017 Q1	$14.5M	Buy	+541,134	New	+$14.9M	0.05%	327
2016 Q4	–	Sell	-451,713	Closed	-$11.3M	–	2826
2016 Q3	$11.3M	Buy	+451,713	New	+$10.5M	0.04%	415
2015 Q3	–	Sell	-92,100	Closed	-$1.32M	–	1573
2015 Q2	$1.32M	Buy	+92,100	New	+$1.56M	0.01%	748
2014 Q3	–	Sell	-60,561	Closed	-$870K	–	1196
2014 Q2	$870K	Buy	+60,561	New	+$791K	﹤0.01%	738
2013 Q4	–	Sell	-13,661	Closed	-$180K	–	1359
2013 Q3	$180K	Buy	+13,661	New	+$179K	﹤0.01%	902

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital's NXTM Position: Q4 2018 in Review

Arrowstreet Capital sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 100,800 shares — an estimated $2.81M sold.

Arrowstreet Capital first reported a position in NXTM in Q3 2013 and held it in 7 quarters. The position peaked at $14.5M in Q1 2017. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

Arrowstreet Capital reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
Arrowstreet Capital sold 100,800 NxStage Medical Inc. shares in Q4 2018, an estimated $2.81M.
Arrowstreet Capital first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 7 quarters.
Arrowstreet Capital's NxStage Medical Inc. position peaked at $14.5M in Q1 2017.
172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Arrowstreet Capital's 13F filing for Q4 2018, filed 14 Feb 2019.